Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients

ConditionsFSHD1FSHD2
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

The goal of this prospective, longitudinal, single-center study is to describe respiratory function in patients affected by FSHD at baseline and after one year using both diaphragmatic ultrasound and pulmonary function test. The primary questions this study aims to answer are:

1. How does respiratory function assessed by diaphragmatic ultrasound and pulmonary function tests change over 12 months in FSHD patients? 2. How accurate is diaphragmatic ultrasound in detecting respiratory abnormalities in these patients compared to pulmonary function tests? 3. What is the relationship between ultrasound and functional indices, and how do these indices correlate with demographic, clinical, and genetic data?

To achieve this, we will enroll a cohort of 34 patients affected by FSHD, and each of them will undergo a comprehensive neurological examination, body plethysmography, measurement of maximal inspiratory pressure (MIP) and maximal espiratory pressure (MEP) and nocturnal oximetry at baseline and after 12 months.

Eligibility criteria

Qualifiers

Diagnosis of FSHD, genetically confirmed.

Adult patients (18 years or older)

Signature from the patient on the written informed consent document

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Diaphragmatic ultrasound
  • Pulmonary function test

Treatment groups

34 Participants
are divided into 1 treatment group